Literature DB >> 6886638

[Cholinesterase (EC 3.1.1.8) with butyrylthiocholine-iodide as substrate: references depending on age and sex with special reference to hormonal effects and pregnancy].

D H den Blaauwen, W A Poppe, W Tritschler.   

Abstract

Referance values are reported for the assay of cholinesterase (substratae: butyrylthiocholine iodide) in serum at 25 degrees C. There was no evidence of any age-dependency or sex-specific distinction in children (1 to 15 years, N = 309), nor were there any age-dependent changes observed in males (16 to 94 years, N = 718). Compared with the reference range for children, there was no detectable difference in the location and distribution of catalytic cholinesterase concentrations. In females (16 to 99 years, N = 861), an age-dependent difference in cholinesterase values became apparent: Regardless of pregnancy or use of hormonal contraceptives, the catalytic concentrations were found to be lower in younger females (16 to 39 years) than in older ones (greater than or equal to 40 years); the reference values in the older age group (40 to 99 years) did not differ from those of males and children. Therefore the following reference values are proposed (in each case 2.5 to 97.5 percentile: Children, males and females above 40 Years: 3.5 to 8.5 kU/l, Females (16-39 years, nonpregnant, not taking hormonal contraceptives): 2.8 to 7.4 kU/l, Females (18-41 years, pregnant or taking hormonal contraceptives): 2.4 to 6.0 kU/l.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6886638

Source DB:  PubMed          Journal:  J Clin Chem Clin Biochem        ISSN: 0340-076X


  10 in total

1.  Biochemical and genetic alterations of oxidant/antioxidant status of the brain in rats treated with dexamethasone: protective roles of melatonin and acetyl-L-carnitine.

Authors:  Naglaa Assaf; Aziza B Shalby; Wagdy K B Khalil; Hanaa H Ahmed
Journal:  J Physiol Biochem       Date:  2011-10-11       Impact factor: 4.158

2.  Exercise enhances the effectiveness of vitamin D therapy in rats with Alzheimer's disease: emphasis on oxidative stress and inflammation.

Authors:  Engy Medhat; Laila Rashed; Marwa Abdelgwad; Basma Emad Aboulhoda; Mohamed Mansour Khalifa; Shimaa Saad El-Din
Journal:  Metab Brain Dis       Date:  2019-11-05       Impact factor: 3.584

3.  Does melatonin ameliorate neurological changes associated with Alzheimer's disease in ovariectomized rat model?

Authors:  Hanaa H Ahmed; Selim F Estefan; Ehab M Mohamd; Abd El-Razik H Farrag; Rania S Salah
Journal:  Indian J Clin Biochem       Date:  2012-12-22

4.  The protective role of parsley extract against vincristine mutagenicity in Drosophila melanogaster.

Authors:  Saleha Y M Alakilli
Journal:  Saudi J Biol Sci       Date:  2010-01       Impact factor: 4.219

5.  Neuroprotective Effects of Simvastatin and Cilostazol in L-Methionine-Induced Vascular Dementia in Rats.

Authors:  Ahmed M El-Dessouki; Mai A Galal; Azza S Awad; Hala F Zaki
Journal:  Mol Neurobiol       Date:  2016-08-20       Impact factor: 5.590

6.  Predicting outcome using butyrylcholinesterase activity in organophosphorus pesticide self-poisoning.

Authors:  M Eddleston; P Eyer; F Worek; M H Rezvi Sheriff; N A Buckley
Journal:  QJM       Date:  2008-03-28

7.  NEUROPROTECTIVE EFFECT OF AMORPHOPHALLUS CAMPANULATUS IN STZ INDUCED ALZHEIMER RAT MODEL.

Authors:  Dong Chen
Journal:  Afr J Tradit Complement Altern Med       Date:  2016-07-03

8.  Potential therapeutic effect of nanobased formulation of rivastigmine on rat model of Alzheimer's disease.

Authors:  Manal Fouad Ismail; Aliaa Nabil Elmeshad; Neveen Abdel-Hameed Salem
Journal:  Int J Nanomedicine       Date:  2013-01-23

9.  Serum butyrylcholinesterase predicts survival after extracorporeal membrane oxygenation after cardiovascular surgery.

Authors:  Klaus Distelmaier; Max-Paul Winter; Kurt Rützler; Gottfried Heinz; Irene M Lang; Gerald Maurer; Herbert Koinig; Barbara Steinlechner; Alexander Niessner; Georg Goliasch
Journal:  Crit Care       Date:  2014-01-30       Impact factor: 9.097

10.  Subclinical involvement of the liver is associated with prognosis in treatment naïve cancer patients.

Authors:  Noemi Pavo; Markus Raderer; Georg Goliasch; Raphael Wurm; Guido Strunk; Anna Cho; Johannes F Novak; Heinz Gisslinger; Günther G Steger; Michael Hejna; Wolfgang Köstler; Sabine Zöchbauer-Müller; Christine Marosi; Gabriela Kornek; Leo Auerbach; Sven Thorben Schneider; Bernhard Parschalk; Werner Scheithauer; Robert Pirker; Barbara Kiesewetter; Richard Pacher; Christoph Zielinski; Martin Hülsmann
Journal:  Oncotarget       Date:  2017-04-16
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.